Igroton
Igroton Brand names, Igroton Analogs
Igroton Brand Names Mixture
- Tenoretic (chlorthalidone + atenolol)
Igroton Chemical_Formula
C14H11ClN2O4S
Igroton RX_link
http://www.rxlist.com/cgi/generic3/chlorthalidone.htm
Igroton fda sheet
Igroton msds (material safety sheet)
Igroton Synthesis Reference
Graf et al.; Helv. Chem.; Acta 42; 1085 (1959); U.S.Pat.3,055,904 (1962)
Igroton Molecular Weight
338.767 g/mol
Igroton Melting Point
218-264oC
Igroton H2O Solubility
120 mg/L
Igroton State
Solid
Igroton LogP
1.718
Igroton Dosage Forms
Tablet
Igroton Indication
For management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.
Igroton Pharmacology
Chlorthalidone, a monosulfonamyl diuretic, differs form other thiazide diuretics in that a double ring system is incorporated into its structure. Chlorthalidone is used alone or with atenolol in the management of hypertension and edema.
Igroton Absorption
Absorbed relatively rapidly after oral administration.
Igroton side effects and Toxicity
Symptoms of overdose include nausea, weakness, dizziness and disturbances of electrolyte balance.
Igroton Patient Information
Patients should inform their physician if they have: (1) had an allergic reaction to chlorthalidone or other diuretics or have asthma, (2) kidney disease, (3) liver disease, (4) gout, (5) systemic lupus erythematosus, or (6) been taking other drugs such as cortisone, digitalis, lithium carbonate, or drugs for diabetes.
Patients should be cautioned to contact their physician if they experience any of the following symptoms of potassium loss: excess thirst, tiredness, drowsiness, restlessness, muscle pains or cramps, nausea, vomiting, or increased heart rate or pulse.
Patients should also be cautioned that taking alcohol can increase the chance of dizziness occurring.
Igroton Organisms Affected
Humans and other mammals
